Abbott Laboratories NewsNews on Abbott Laboratories continually updated from thousands of sources around the net.NeuroSearch (XETRA) -- July 6, 2008 NeuroSearch is a Scandinavian biopharmaceutical company listed on the OMX Nordic Exchange Copenhagen AS. Our core business covers the development of novel drugs, based on a broad and well-established drug ...http://www.topix.net/com/abt/2008/07/neurosearch-xetra?fromrss=1 Abbott Laboratories (ABT): Bill Nygren Sold out in ABT- July 4, 2008 GuruFocus Home >> Stock Ideas >> Recent Picks >> Abbott Laboratories ABT - Abbott Laboratories $81.8 Bil 11.74% 18.15 27.4% 4.61 18.59% 3.16 14.39% 2.72% 45% $2.92 1543.3 Mil Abbott Laboratories is a global ...http://www.topix.net/com/abt/2008/07/abbott-laboratories-abt-bill-nygren-sold-out-in-abt?f... New stent OK'd for marketing- July 4, 2008 Federal regulators Wednesday approved Abbott Laboratories' drug-coated stent Xience V for sale in the United States, opening up a long-term -- and potentially very lucrative -- market for a product manufactured ...http://www.topix.net/com/abt/2008/07/new-stent-okd-for-marketing?fromrss=1 Closing Bell: Bulls drinking with bears out on a kitchen pass- July 3, 2008 Posted Jul 3rd 2008 1:10PM by Jon Ogg Filed under: Abbott Laboratories Today was a good end to a strange trading week, while many shares had light volume with today's half-day trading session.http://www.topix.net/com/abt/2008/07/closing-bell-bulls-drinking-with-bears-out-on-a-kitch... FDA approvas Boston Scientific stent- July 3, 2008 Boston Scientific Corp. announced Wednesday that the U.S. Food and Drug Administration has approved the company's Promus drug-coated coronary stent.http://www.topix.net/com/abt/2008/07/fda-approvas-boston-scientific-stent?fromrss=1 Abbotts' Xience stent gets FDA approval- July 2, 2008 Abbott Laboratories won U.S. approval for its Xience heart stent, a product analysts predict will lead a $4 billion-a-year market for the artery-opening devices.http://www.topix.net/com/abt/2008/07/abbotts-xience-stent-gets-fda-approval?fromrss=1 Abbott Laboratories EVP exercises options- July 2, 2008 An executive vice president of pharmaceutical company Abbott Laboratories exercised options for 13,392 shares of common stock, according to a filing with the Securities and Exchange Commission.http://www.topix.net/com/abt/2008/07/abbott-laboratories-evp-exercises-options?fromrss=1 Abbott Laboratories Invests Additional $20M in Subsidiary Ibis Biosciences- July 1, 2008 Isis Pharmaceuticals, Inc. announced today that Abbott has invested an additional $20 million in Ibis Biosciences, Inc., an Isis subsidiary.http://www.topix.net/com/abt/2008/07/abbott-laboratories-invests-additional-20m-in-subsidi... Judge Kills IP Claim, Blames Lawyer- July 1, 2008 Finding that an in-house lawyer tried to deceive the U.S. Patent and Trademark Office, a federal judge ruled Abbott Laboratories' patent unenforceable.http://www.topix.net/com/abt/2008/06/judge-kills-ip-claim-blames-lawyer?fromrss=1 |